The importance of age as prognostic factor for the outcome of patients with hepatoblastoma: Analysis from the Children's Hepatic tumors International Collaboration (CHIC) database-Reference-Cited by-同舟云学术

The importance of age as prognostic factor for the outcome of patients with hepatoblastoma: Analysis from the Children's Hepatic tumors International Collaboration (CHIC) database

Published:2020-05-08 Issue:8 Volume:67 Page:
ISSN:1545-5009
Container-title:Pediatric Blood & Cancer
language:en
Short-container-title:Pediatr Blood Cancer

Author:

Haeberle Beate¹,Rangaswami Arun²,Krailo Mark³,Czauderna Piotr⁴,Hiyama Eiso⁵,Maibach Rudolf⁶,Lopez‐Terrada Dolores⁷,Aronson Daniel C.⁸,Alaggio Rita⁹,Ansari Marc¹⁰,Malogolowkin Marcio H.¹¹,Perilongo Giorgio¹²,O'Neill Allison F.¹³,Trobaugh‐Lotrario Angela D.¹⁴,Watanabe Kenichiro¹⁵,Schmid Irene¹⁶,Schweinitz Dietrich¹,Ranganathan Sarangarajan¹⁷,Yoshimura Kenichi¹⁸,Hishiki Tomoro¹⁹,Tanaka Yukichi²⁰,Piao Jin³,Feng Yurong²¹,Rinaldi Eugenia²²,Saraceno Davide²²,Derosa Marisa²²,Meyers Rebecka L.²³

Affiliation:

1. Division of Pediatric SurgeryUniversity of Munich Munich Germany

2. Division of Pediatric Hematology and OncologyUniversity of California San Francisco San Francisco California

3. Department of Preventive MedicineUniversity of Southern CaliforniaCalifornia Los Angeles

4. Department of Surgery for Children and AdolescentsMedical University of Gdansk Gdansk Poland

5. Department of Pediatric SurgeryHiroshima University Hiroshima Japan

6. IBCSG Coordinating Center Bern Switzerland

7. Department of Pathology and ImmunologyBaylor College of Medicine Houston Texas

8. Department of Pediatric SurgeryUniversity Children's Hospital Zurich Zurich Switzerland

9. Department of PathologyBambino Gesu Pediatric Hospital Roma Italy

10. Pediatric DepartmentOnco‐Hematology UnitGeneva University Hospital Geneva Switzerland

11. Division of Pediatric Hematology OncologyUniversity of California Davis Comprehensive Cancer CenterCalifornia Sacramento

12. Department of PediatricsUniversity of Padua Padua Italy

13. Department of Pediatric OncologyDana‐Farber Cancer InstituteBoston Children's Hospital and Harvard Medical School Boston Massachusetts

14. Department of Pediatric Hematology/OncologyProvidence Sacred Heart Children's Hospital Spokane Washington

15. Department of Hematology and OncologyShizuoka Children's Hospital Shizuoka Japan

16. Department of Pediatric Hematology and OncologyUniversity of Munich Munich Germany

17. Division of Pathology and Laboratory MedicineCincinnati Children's Hospital Mediacla Center Cincinnati Ohio

18. Innovative Clinical Research Center (iCREK)Kanazawa University Hospital Japan

19. Department of Pediatric SurgeryChiba University Graduate School of Medicine Chiba Japan

20. Department of PathologyKanagawa Children's Medical Center Yokohama Japan

21. Children's Oncology Group Los Angeles California

22. CINECA Bologna Italy

23. Division of Pediatric SurgeryUniversity of Utah School of MedicineUtah Salt Lake City

Funder

Krebsforschung Schweiz

Publisher

Wiley

Subject

Oncology,Hematology,Pediatrics, Perinatology, and Child Health

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/pbc.28350

Reference35 articles.

1. Hepatoblastoma state of the art

2. Malignant tumors of the liver in children

3. Dose-dense cisplatin-based chemotherapy and surgery for children with high-risk hepatoblastoma (SIOPEL-4): a prospective, single-arm, feasibility study

4. The treatment of hepatoblastoma: Its evolution and the current status as per the SIOPEL trials

5. Randomized Comparison of Cisplatin/Vincristine/Fluorouracil and Cisplatin/Continuous Infusion Doxorubicin for Treatment of Pediatric Hepatoblastoma: A Report From the Children’s Cancer Group and the Pediatric Oncology Group

Cited by 36 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Upfront or delayed surgery in resectable hepatoblastoma: analysis from the children’s hepatic tumors international collaboration database;eClinicalMedicine;2024-10

2. Hepatoblastoma: A Case Report;Asploro Journal of Biomedical and Clinical Case Reports;2024-08-19

3. Hepatic resections for pediatric hepatoblastoma: analysis of 30-day outcomes using the National Surgical Quality Improvement Program—Pediatric database;Pediatric Surgery International;2024-08-17

4. Successful treatment of young childhood standard‐risk hepatoblastoma with cisplatin monotherapy using a central review system;Pediatric Blood & Cancer;2024-08-10

5. IMPDH2 suppression impedes cell proliferation by instigating cell cycle arrest and stimulates apoptosis in pediatric hepatoblastoma;Journal of Cancer Research and Clinical Oncology;2024-08-01